NCT04416308View on ClinicalTrials.gov

COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)

NACompletedINTERVENTIONAL
Enrollment

9,453

Participants

Timeline

Start Date

May 29, 2020

Primary Completion Date

July 10, 2020

Study Completion Date

October 12, 2020

Conditions
Coronavirus
Interventions
DIAGNOSTIC_TEST

NG test

rapid diagnosis Covid 19

DIAGNOSTIC_TEST

Blood test

sample

BEHAVIORAL

Self-questionnary

behavioral survey

Trial Locations (9)

35000

Chu Rennes, Rennes

35130

CENTRE HOSPITALIER de VITRE_ Saint Jean (La Guerche), La Guerche-de-Bretagne

35150

Centre Hospitalier de La Roche Aux Fees, Janzé

35162

Centre Hospitalier Montfort-Sur-Meu, Montfort-sur-Meu

35290

Centre Hospitalier St Meen Le Grand, Saint-Méen-le-Grand

35300

Centre Hospitalier de Fougeres, Fougères

35390

Centre Hospitalier Grand Fougeray, Grand-Fougeray

35506

CENTRE HOSPITALIER VITRE_Simone Veil, Vitré

35603

Centre Hospitalier de Redon Carentoir, Redon

All Listed Sponsors
collaborator

Fonds NOMINOE

UNKNOWN

lead

Rennes University Hospital

OTHER

NCT04416308 - COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) | Biotech Hunter | Biotech Hunter